The 66th Edition of the British National Formulary has been published and it is currently being distributed in the NHS.
New or revised content in this version includes updated advice in the following areas:
- New restrictions on the use of cilostazol
- Updated paediatric dose information for rifampicin and ethambutol for the treatment of tuberculosis
- Updated driving guidance for patients with diabetes mellitus
- New advice on the risk of atypical femoral fractures with denosumab
- Updated advice on the risk of serious cardiovascular disease with strontium ranelate
- Updated immunisation schedule for meningococcal group C conjugate and rotavirus vaccines
Action: All clinicians should start using BNF 66 as soon as the print version arrives. The web version can be used to access the latest information if necessary.
|« Antimicrobial Resistance Strategy||NICE Guidance - September 2013 »|